Charity healthcare dollars aren’t making it to the patients

Published October 11, 2024 12:46pm ET



One of the most common and false tropes about right-wingers is that they simply do not care about the poor. In reality, most on the Right oppose government funding for charity projects because they’re well aware that the money gets misused, ends up making the problem worse, and rarely meaningfully improves the lives of its targets — if it even makes it to individual citizens to begin with. Such is the case with the 340B Drug Pricing Program. 

Most people are probably unaware it even exists, but the 340B drug discount program was designed to reduce drug costs for healthcare providers that serve patients regardless of their ability to pay or insurance by offering them a revenue stream to support their services. The legislation mandates that pharmaceutical companies offer discounts to qualifying safety-net healthcare providers in return for having their medications included under Medicaid and Medicare Part B. 

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.